N-(2,6-di(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl)benzamide

ID: ALA5088545

PubChem CID: 166636019

Max Phase: Preclinical

Molecular Formula: C22H15N3OS2

Molecular Weight: 401.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1c(-c2cccs2)nc2ccc(-c3cccs3)cn12)c1ccccc1

Standard InChI:  InChI=1S/C22H15N3OS2/c26-22(15-6-2-1-3-7-15)24-21-20(18-9-5-13-28-18)23-19-11-10-16(14-25(19)21)17-8-4-12-27-17/h1-14H,(H,24,26)

Standard InChI Key:  JKRZCIMCPLKHFV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   32.7826  -11.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7826  -12.1464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4879  -12.5509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4879  -10.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1931  -11.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1931  -12.1429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.9669  -12.3944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4453  -11.7361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9670  -11.0779    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2605  -11.7366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7409  -12.3977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5181  -12.1452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5181  -11.3279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7409  -11.0756    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   35.2194  -13.1717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.6725  -13.7789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9250  -14.5561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8732  -13.6089    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3774  -15.1594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6293  -15.9360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4294  -16.1066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9771  -15.4945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7223  -14.7202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0778  -12.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3308  -12.2270    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   30.7849  -12.8351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1945  -13.5423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9936  -13.3711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  1  0
  8 10  1  0
  7 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 17  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  2  0
  2 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5088545

    ---

Associated Targets(Human)

GABRA4 Tclin Gamma-aminobutyric acid receptor subunit alpha-4/beta-1/delta (32 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.52Molecular Weight (Monoisotopic): 401.0657AlogP: 6.04#Rotatable Bonds: 4
Polar Surface Area: 46.40Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.10CX LogP: 5.18CX LogD: 5.18
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.40Np Likeness Score: -1.80

References

1. Rostrup F, Falk-Petersen CB, Harpso E K, Buchleithner S, Conforti I, Jung S, Gloriam DE, Schirmeister T, Wellendorph P, Fro Lund B..  (2021)  Structural Determinants for the Mode of Action of Imidazopyridine DS2 at δ-Containing γ-Aminobutyric Acid Type A Receptors.,  64  (8.0): [PMID:33847501] [10.1021/acs.jmedchem.0c02163]

Source